Lv7
5000 积分 2020-04-21 加入
非奈利酮联合达格列净治疗糖尿病肾病的临床研究
8天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
29天前
已完结
Anti-TL1A antibody, afimkibart, in moderately-to-severely active ulcerative colitis (TUSCANY-2): a multicentre, double-blind, treat-through, multi-dose, randomised, placebo-controlled, phase 2b trial
29天前
已完结
混合型高脂血症基层诊疗中国专家共识（2024年）
1个月前
已完结
Vunakizumab for Radiographic Axial Spondyloarthritis A Randomized Clinical Trial
2个月前
已完结
Vunakizumab for Radiographic Axial Spondyloarthritis: A Randomized Clinical Trial
3个月前
已完结
中国缺血性卒中和短暂性脑缺血发作二级预防指南2022
3个月前
已完结
急性气管-支气管炎基层诊疗指南（2018年）
4个月前
已完结
Efficacy and safety of monoclonal antibody AK111 in the treatment of active ankylosing spondylitis: a randomised, double-blind, placebo-controlled, multicentre phase II clinical study
6个月前
已完结
皖公网安备34019202002308
